Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-120-3 | CAS number: 103-53-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Toxic properties after a single oral dose of the test substance were investigated by observation for a period of 15 days.
- GLP compliance:
- no
- Limit test:
- yes
- Species:
- guinea pig
- Strain:
- not specified
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- other: sunflower-seed oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 20-45%
- Amount of vehicle (if gavage):0.2-0.5 mL/kg bw
- Justification for choice of vehicle: because of low solubility of the substance - Doses:
- 0.2 to 0.5 mL/kg bw of 20-45% solution in the vehicle
- No. of animals per sex per dose:
- 6 animals/sex/dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 15 days
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 4 500 mg/kg bw
- Based on:
- test mat.
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008
- Conclusions:
- The test substance has a LD50 of 4500 mg/kg bw given as a single dose.
- Executive summary:
The study has been performed in order to investigate the toxic propreties of the test substance.
Each groups of 6 males and 6 females of guinea pigs were fed through a stomach tube perorally in the form of a 20 -45% solution in sunflower-seed oil (0.2 - 0.5 mL per kg bw) given as a single dose.
The animals were observed for 15 days.
No differences in the sex sensitivity of these animals were observed.
As a result, the test substance can be referred to as a low-toxic compound with an LD50 of 4500 mg/kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Toxic properties after a single oral dose of the test substance were investigated by observation for a period of 15 days.
- GLP compliance:
- no
- Limit test:
- yes
- Species:
- mouse
- Strain:
- other: White/CD-1
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- other: sunflower-seed oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 20-45%
- Amount of vehicle (if gavage):0.2-0.5 mL/kg bw
- Justification for choice of vehicle: because of low solubility of the substance - Doses:
- 0.2 to 0.5 mL/kg bw of 20-45% solution in the vehicle
- No. of animals per sex per dose:
- 6 animals/sex/dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 15 days
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 4 500 mg/kg bw
- Based on:
- test mat.
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008
- Conclusions:
- The test substance has a LD50 of 4500 mg/kg bw given as a single dose.
- Executive summary:
The study has been performed in order to investigate the toxic propreties of the test substance.
Each groups of 6 males and 6 females of White/CD-1 mice were fed through a stomach tube perorally in the form of a 20 -45% solution in sunflower-seed oil (0.2 - 0.5 mL per kg bw) given as a single dose.
The animals were observed for 15 days.
No differences in the sex sensitivity of these animals were observed.
As a result, the test substance can be referred to as a low-toxic compound with an LD50 of 4500 mg/kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- Toxic properties after a single oral dose of the test substance were investigated by observation for a period of 15 days.
- GLP compliance:
- no
- Limit test:
- yes
- Species:
- rat
- Strain:
- other: Albino
- Sex:
- male/female
- Route of administration:
- oral: gavage
- Vehicle:
- other: sunflower-seed oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 20-45%
- Amount of vehicle (if gavage):0.2-0.5 mL/kg bw
- Justification for choice of vehicle: because of low solubility of the substance - Doses:
- 0.2 to 0.5 mL/kg bw of 20-45% solution in the vehicle
- No. of animals per sex per dose:
- 6 animals/sex/dose
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 15 days
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 4 500 mg/kg bw
- Based on:
- test mat.
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008
- Conclusions:
- The test substance has a LD50 of 4500 mg/kg bw given as a single dose.
- Executive summary:
The study has been performed in order to investigate the toxic propreties of the test substance.
Each groups of 6 males and 6 females of albino rats were fed through a stomach tube perorally in the form of a 20 -45% solution in sunflower-seed oil (0.2 - 0.5 mL per kg bw) given as a single dose.
The animals were observed for 15 days.
No differences in the sex sensitivity of these animals were observed.
As a result, the test substance can be referred to as a low-toxic compound with an LD50 of 4500 mg/kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Principles of method if other than guideline:
- No detailed information is available on the test method.
- GLP compliance:
- no
- Limit test:
- yes
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Route of administration:
- oral: unspecified
- Vehicle:
- not specified
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 10
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: daily
- Other examinations performed: clinical signs - Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 5 000 mg/kg bw
- Mortality:
- 5 out of 10 animals died on day 1.
- Clinical signs:
- Lethargy
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008
- Conclusions:
- The test item tested via oral route has an LD50 of 5000 mg/kg bw.
- Executive summary:
In the current test the acute toxicity via the oral route of the test item was assessed in rats. A single dose of 5000 mg/kg bw of the test substance was given to 10 animals. 5 out of 10 animals died and therefore the LD50 is 5000 mg/kg bw.
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Principles of method if other than guideline:
- No detailed information is available on the test method.
- GLP compliance:
- no
- Limit test:
- yes
- Species:
- mouse
- Strain:
- not specified
- Sex:
- not specified
- Route of administration:
- oral: unspecified
- Vehicle:
- not specified
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 10
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: daily - Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- > 5 000 mg/kg bw
- Mortality:
- No animals died.
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008
- Conclusions:
- The LD50 for acute oral toxicity was greater than 5000 mg/kg bw.
- Executive summary:
- In the current test the acute toxicity of the test item via the oral route was assessed in mice. A single dose of 5000 mg/kg bw of the test substance was given to 10 animals. No animals died and therefore the LD50 > 5000 mg/kg bw.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 4 500 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Principles of method if other than guideline:
- No information on test method available.
- GLP compliance:
- no
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
- Type of coverage:
- not specified
- Vehicle:
- not specified
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 10 animals in total
- Control animals:
- not specified
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- >= 5 000 mg/kg bw
- Mortality:
- 0/10
- Clinical signs:
- Diarrhea in 2 animals out of 10 on day 1.
Slight redness in 2 out of 10 animals; slight edema in 1 out of 10. - Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008
- Conclusions:
- The test item tested via dermal route had an LD50 greater than 5000 mg/kg bw
- Executive summary:
In the current test the acute toxicity via the dermal route of the test item was assessed in rabbits. A single dose of 5000 mg/kg bw of the test substance was applied to 10 animals. No animals died and therefore the LD50 > 5000 mg/kg bw. Slight erythema was observed in 2/10 animals, slight edema in 1/10. Furthermore, 2 rabbits had diarrhea on day 1.
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- documentation insufficient for assessment
- Principles of method if other than guideline:
- No information on test method available.
- GLP compliance:
- no
- Limit test:
- yes
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
- Type of coverage:
- not specified
- Vehicle:
- not specified
- Doses:
- 5000 mg/kg bw
- No. of animals per sex per dose:
- 4 animals in total
- Control animals:
- not specified
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations: daily
- Other examinations performed: skin reactions (erythema, edema) - Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- >= 5 000 mg/kg bw
- Mortality:
- No animals died.
- Clinical signs:
- No erythema or edema observed.
- Interpretation of results:
- other: CLP/EU GHS criteria not met, no classification required according to Regulation (EC) No. 1272/2008
- Conclusions:
- The test item tested via dermal route had an LD50 greater than 5000 mg/kg bw.
- Executive summary:
In the current test the acute toxicity via the dermal route of the test item was assessed in rabbits. A single dose of 5000 mg/kg bw of the test substance was applied to 4 animals. No animals died and therefore the LD50 > 5000 mg/kg bw. No erythema or edema was observed.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
Additional information
Acute oral toxicity
There are 5 studies available assessing the acute toxicity of the test item via the oral route.
None of these studies is performed according to internationally accepted guidelines, and the documentation of the test method and results is in general limited. The studies are therefore all assigned a Klimisch 4 score. Nevertheless, as the outcome of all studies consistently shows a very low acute toxicity, a weight of evidence approach is used in order to fulfil the information requirements for this endpoint, and to determine the classification of the test substance. Additional testing is deemed to not bring new information to the acute toxicity assessment, and hence is omitted in order to avoid unnecessary vertebrate animal testing.
The publication by Zaitsev (1973) addresses the oral acute toxicity to rats, mice and guinea pigs by dosing the test substance dissolved in sunflower-seed oil via oral gavage. 3 Male and 3 female animals were dosed per experiment. The animals were observed for 15 days following the single exposure. Each of these 3 experiments resulted in an LD50 value of 4500 mg/kg bw.
In the second study (Leberco Laboratories, 1975) a single dose of 5000 mg/kg bw was given to 10 rats, none of which died. Hence, the LD50 was determined to be > 5000 mg/kg bw.
In the third study (MB Research Laboratories, 1975) a single dose of 5000 mg/kg bw of the test substance was given to 10 rats. 5 Out of 10 died, leading to the conclusion that the LD50 is 5000 mg/kg bw.
The above experiments allow to conclude by weight of evidence that the substance exerts only low acute oral toxicity. Classification according to the CLP Regulation No 1272/2008 is not necessary as the LD50 is higher than 2000 mg/kg bw.
Acute dermal toxicity
There are 2 studies available assessing the acute toxicity of the test item via the dermal route. The documentation on the study method and results is limited, hence a Klimisch 4 score is deemed appropriate. In the first test, 10 rabbits were exposed to 5000 mg/kg bw and were observed for 14 days (MB Research Laboratories, 1975). In the second study the same dose was tested on 4 rabbits (Leberco Laboratories, 1975). In both experiments no animals died in the course of the observation period. Hence, the dermal LD50 of the test item was found to be >5000 mg/kg bw. As a consequence, classification according to the CLP Regulation No 1272/2008 is not necessary. These results further prove the low acute toxicity of the test substance.
Justification for classification or non-classification
Acute oral toxicity
According to the CLP legislation a substance is considered acute toxic when the acute toxicity estimates (ATE) for the oral route are =< 2000 mg/kg bodyweight. As the LD50 of the test item > 2000 mg/kg bw, the substance has not to be classified as acute toxic for the oral route.
Acute dermal toxicity
According to the CLP legislation a substance is considered acute toxic when the acute toxicity estimates (ATE) for the dermal route are =< 2000 mg/kg bodyweight. As the LD50 of the test item > 2000 mg/kg bw, the substance has not to be classified as acute toxic for the dermal route.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.